These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 33430239)
1. CD73, Tumor Plasticity and Immune Evasion in Solid Cancers. Yang H; Yao F; Davis PF; Tan ST; Hall SRR Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33430239 [TBL] [Abstract][Full Text] [Related]
2. Cell type- and tissue-specific functions of ecto-5'-nucleotidase (CD73). Minor M; Alcedo KP; Battaglia RA; Snider NT Am J Physiol Cell Physiol; 2019 Dec; 317(6):C1079-C1092. PubMed ID: 31461341 [TBL] [Abstract][Full Text] [Related]
3. Dual role of CD73 as a signaling molecule and adenosine-generating enzyme in colorectal cancer progression and immune evasion. Lian W; Jiang D; Lin W; Jiang M; Zhang Y; Wang H; Zhao L Int J Biol Sci; 2024; 20(1):137-151. PubMed ID: 38164172 [TBL] [Abstract][Full Text] [Related]
4. Methotrexate up-regulates ecto-5'-nucleotidase/CD73 and reduces the frequency of T lymphocytes in the glioblastoma microenvironment. Figueiró F; de Oliveira CP; Bergamin LS; Rockenbach L; Mendes FB; Jandrey EH; Moritz CE; Pettenuzzo LF; Sévigny J; Guterres SS; Pohlmann AR; Battastini AM Purinergic Signal; 2016 Jun; 12(2):303-12. PubMed ID: 26910734 [TBL] [Abstract][Full Text] [Related]
5. CD73 as a potential opportunity for cancer immunotherapy. Ghalamfarsa G; Kazemi MH; Raoofi Mohseni S; Masjedi A; Hojjat-Farsangi M; Azizi G; Yousefi M; Jadidi-Niaragh F Expert Opin Ther Targets; 2019 Feb; 23(2):127-142. PubMed ID: 30556751 [TBL] [Abstract][Full Text] [Related]
6. Targeting CD73 to augment cancer immunotherapy. Roh M; Wainwright DA; Wu JD; Wan Y; Zhang B Curr Opin Pharmacol; 2020 Aug; 53():66-76. PubMed ID: 32777746 [TBL] [Abstract][Full Text] [Related]
7. Targeting the Immunomodulatory CD73/Adenosine System to Improve the Therapeutic Gain of Radiotherapy. de Leve S; Wirsdörfer F; Jendrossek V Front Immunol; 2019; 10():698. PubMed ID: 31024543 [TBL] [Abstract][Full Text] [Related]
8. The CD73/Ado System-A New Player in RT Induced Adverse Late Effects. de Leve S; Wirsdörfer F; Jendrossek V Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31623231 [TBL] [Abstract][Full Text] [Related]
9. GRHL2 suppression of NT5E/CD73 in breast cancer cells modulates CD73-mediated adenosine production and T cell recruitment. Coban B; Wang Z; Liao CY; Beslmüller K; Timmermans MAM; Martens JWM; Hundscheid JHM; Slutter B; Zweemer AJM; Neubert E; Danen EHJ iScience; 2024 May; 27(5):109738. PubMed ID: 38706844 [TBL] [Abstract][Full Text] [Related]
10. Controlling the Immune Suppressor: Transcription Factors and MicroRNAs Regulating CD73/NT5E. Kordaß T; Osen W; Eichmüller SB Front Immunol; 2018; 9():813. PubMed ID: 29720980 [TBL] [Abstract][Full Text] [Related]
11. Engineered natural killer cells impede the immunometabolic CD73-adenosine axis in solid tumors. Chambers AM; Lupo KB; Wang J; Cao J; Utturkar S; Lanman N; Bernal-Crespo V; Jalal S; Pine SR; Torregrosa-Allen S; Elzey BD; Matosevic S Elife; 2022 Jul; 11():. PubMed ID: 35815945 [TBL] [Abstract][Full Text] [Related]
12. Unraveling the Intricacies of CD73/Adenosine Signaling: The Pulmonary Immune and Stromal Microenvironment in Lung Cancer. Saigí M; Mesía-Carbonell O; Barbie DA; Guillamat-Prats R Cancers (Basel); 2023 Dec; 15(23):. PubMed ID: 38067409 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of Ecto-5'-nucleotidase (CD73) promotes T-47D human breast cancer cells invasion and adhesion to extracellular matrix. Zhou P; Zhi X; Zhou T; Chen S; Li X; Wang L; Yin L; Shao Z; Ou Z Cancer Biol Ther; 2007 Mar; 6(3):426-31. PubMed ID: 17471030 [TBL] [Abstract][Full Text] [Related]
14. The ubiquitin-specific peptidase 22 is a deubiquitinase of CD73 in breast cancer cells. Gregory S; Xu Y; Xie P; Fan J; Gao B; Mani N; Iyer R; Tang A; Wei J; Chaudhuri SM; Wang S; Liu H; Zhang B; Fang D Am J Cancer Res; 2022; 12(12):5564-5575. PubMed ID: 36628293 [TBL] [Abstract][Full Text] [Related]
15. Specific Activation of A3, A2A and A1 Adenosine Receptors in CD73-Knockout Mice Affects B16F10 Melanoma Growth, Neovascularization, Angiogenesis and Macrophage Infiltration. Koszałka P; Gołuńska M; Urban A; Stasiłojć G; Stanisławowski M; Majewski M; Składanowski AC; Bigda J PLoS One; 2016; 11(3):e0151420. PubMed ID: 26964090 [TBL] [Abstract][Full Text] [Related]
16. Ecto-5'-nucleotidase/CD73 enhances endothelial barrier function and sprouting in blood but not lymphatic vasculature. Yegutkin GG; Auvinen K; Rantakari P; Hollmén M; Karikoski M; Grénman R; Elima K; Jalkanen S; Salmi M Eur J Immunol; 2015 Feb; 45(2):562-73. PubMed ID: 25402681 [TBL] [Abstract][Full Text] [Related]
17. Complex regulation of ecto-5'-nucleotidase/CD73 and A Nedeljkovic N Pharmacol Res; 2019 Jun; 144():99-115. PubMed ID: 30954629 [TBL] [Abstract][Full Text] [Related]
18. Role of CD73 in Disease: Promising Prognostic Indicator and Therapeutic Target. Yang J; Liao X; Yu J; Zhou P Curr Med Chem; 2018; 25(19):2260-2271. PubMed ID: 29345574 [TBL] [Abstract][Full Text] [Related]